^
CANCER:

Tenosynovial Giant Cell Tumor

No biomarker
Tenosynovial Giant Cell Tumor
pexidartinib
Sensitive: A1 - Approval
COL6A3-CSF1 fusion
Tenosynovial Giant Cell Tumor
gefitinib + mitoxantrone
Sensitive: C4 – Case Studies